MediWound (MDWD) News Today $17.90 +0.63 (+3.65%) (As of 11:07 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s FutureDecember 17 at 9:56 PM | markets.businessinsider.comStrategic Growth and Market Potential Drive Buy Rating for MediWound Despite Revenue DeclineDecember 6, 2024 | markets.businessinsider.comBrokers Offer Predictions for MediWound FY2024 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Equities research analysts at HC Wainwright decreased their FY2024 EPS estimates for MediWound in a research note issued on Wednesday, November 27th. HC Wainwright analyst S. Ramakanth now anticipates that the biopharmaceutical company will post earninDecember 2, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Stock, Option ChainNovember 28, 2024 | benzinga.comMediWound (NASDAQ:MDWD) Given New $25.00 Price Target at HC WainwrightHC Wainwright cut their price objective on MediWound from $28.00 to $25.00 and set a "buy" rating for the company in a report on Wednesday.November 27, 2024 | marketbeat.comMediWound Advances Enzymatic Therapeutics Amid Financial ShiftsNovember 27, 2024 | markets.businessinsider.comMediwound’s Promising Outlook: Expansion and Trials Support Buy RatingNovember 26, 2024 | markets.businessinsider.comMediWound Ltd. (MDWD) Q3 2024 Earnings Call TranscriptNovember 26, 2024 | seekingalpha.comMediWound Reports Third Quarter 2024 Financial Results and Provides Company UpdateNovember 26, 2024 | globenewswire.comEarnings Preview: MediWoundNovember 25, 2024 | benzinga.comWhat To Expect From MediWound Ltd (MDWD) Q3 2024 EarningsNovember 25, 2024 | finance.yahoo.comMediWound (MDWD) to Release Earnings on TuesdayMediWound (NASDAQ:MDWD) will be releasing earnings before the market opens on Tuesday, November 26, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=648662)November 19, 2024 | marketbeat.comMediWound to Discuss New Share Incentive PlanNovember 14, 2024 | markets.businessinsider.comMediWound to Report Third Quarter 2024 Financial ResultsNovember 12, 2024 | finance.yahoo.comARK Investment Management LLC Invests $1.81 Million in MediWound Ltd. (NASDAQ:MDWD)ARK Investment Management LLC acquired a new stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 99,994 shares of the biopharmaceutical company'sNovember 9, 2024 | marketbeat.comRosalind Advisors Inc. Has $11.34 Million Stock Holdings in MediWound Ltd. (NASDAQ:MDWD)Rosalind Advisors Inc. grew its position in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 22.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 628,050 shares of the biopharmaceutical company's stock after acquiring an additiNovember 6, 2024 | marketbeat.comMediWound Is A Healthy InvestmentOctober 29, 2024 | seekingalpha.comMediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last yearOctober 27, 2024 | finance.yahoo.comRosalind Advisors, Inc. Increases Stake in MediWound LtdOctober 24, 2024 | uk.finance.yahoo.comMediWound (NASDAQ:MDWD) Stock Quotes, Forecast and News SummaryOctober 14, 2024 | benzinga.comMediwound’s EscharEx Poised for Growth: A Comprehensive Valuation and Buy Rating Amidst Clinical StudiesOctober 11, 2024 | markets.businessinsider.comMediWound (NASDAQ:MDWD) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $28.00 price target on shares of MediWound in a research note on Friday.October 11, 2024 | marketbeat.comMediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg UlcersOctober 10, 2024 | globenewswire.comMediWound (NASDAQ:MDWD) Stock Passes Below 200 Day Moving Average of $16.99MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200 Day Moving Average of $16.99September 11, 2024 | marketbeat.comMediWound to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | markets.businessinsider.comMediWound (NASDAQ:MDWD) Shares Cross Above 50 Day Moving Average of $18.20MediWound (NASDAQ:MDWD) Stock Crosses Above 50-Day Moving Average of $18.20September 3, 2024 | marketbeat.comMediwound Poised for Growth: Buy Rating Backed by NexoBrid Expansion and EscharEx Market PotentialAugust 22, 2024 | markets.businessinsider.comMediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutionsAugust 21, 2024 | finance.yahoo.comBrokers Set Expectations for MediWound Ltd.'s Q3 2024 Earnings (NASDAQ:MDWD)MediWound Ltd. (NASDAQ:MDWD - Free Report) - Analysts at HC Wainwright raised their Q3 2024 earnings estimates for MediWound in a research report issued on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biopharmaceutical company will post earnings per share of ($0.August 19, 2024 | marketbeat.comFY2027 EPS Estimates for MediWound Ltd. Cut by HC Wainwright (NASDAQ:MDWD)MediWound Ltd. (NASDAQ:MDWD - Free Report) - Research analysts at HC Wainwright dropped their FY2027 earnings estimates for MediWound in a report issued on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biopharmaceutical company will post earnings per share of $1.2August 16, 2024 | marketbeat.comMediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal BurnsAugust 15, 2024 | globenewswire.comBuy Rating Justified by MediWound’s Strong Financials and Product Expansion PotentialAugust 15, 2024 | markets.businessinsider.comMediWound (NASDAQ:MDWD) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and set a $28.00 price target on shares of MediWound in a research note on Thursday.August 15, 2024 | marketbeat.comMediWound Q2 2024 Earnings PreviewAugust 15, 2024 | msn.comBuy Rating Affirmed for Mediwound Amid Market Expansion and Positive Growth ProspectsAugust 15, 2024 | markets.businessinsider.comMediWound Ltd. (MDWD) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comMediWound Ltd.: MediWound Reports Second Quarter 2024 Financial Results and Provides Company UpdateAugust 14, 2024 | finanznachrichten.deMediWound Reports Second Quarter 2024 Financial Results and Provides Company UpdateAugust 14, 2024 | globenewswire.comAST SpaceMobile (ASTS) to Post Q2 Earnings: What's in the Cards?August 12, 2024 | msn.comMediWound (MDWD) Set to Announce Earnings on WednesdayMediWound (NASDAQ:MDWD) will be releasing earnings before the market opens on Wednesday, August 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=617296)August 7, 2024 | marketbeat.comStockNews.com Upgrades MediWound (NASDAQ:MDWD) to SellStockNews.com upgraded MediWound to a "sell" rating in a research report on Monday.August 5, 2024 | marketbeat.comMediWound Ltd.: MediWound Announces Positive Results from the U.S. NexoBrid Expanded Access Protocol (NEXT)August 5, 2024 | finanznachrichten.deMediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)August 5, 2024 | globenewswire.comMediWound to Report Second Quarter 2024 Financial ResultsAugust 2, 2024 | globenewswire.comMediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg UlcersJuly 29, 2024 | globenewswire.comMediWound Ltd. (MDWD)July 28, 2024 | finance.yahoo.com29,948 Shares in MediWound Ltd. (NASDAQ:MDWD) Purchased by Janney Montgomery Scott LLCJanney Montgomery Scott LLC acquired a new position in MediWound Ltd. (NASDAQ:MDWD - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 29,948 shares of the biopharmaceutical company's stock, vaJuly 23, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Receives "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $28.00 target price on shares of MediWound in a research note on Tuesday.July 16, 2024 | marketbeat.comMediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator ProgramJuly 16, 2024 | globenewswire.comMölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound LtdJuly 15, 2024 | prnewswire.com Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address "X-Ray Vision" could find thousands of hidden market opportunities (Ad)Let me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines. Just tap here to join the presentation. MDWD Media Mentions By Week MDWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDWD News Sentiment▼1.340.59▲Average Medical News Sentiment MDWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDWD Articles This Week▼11▲MDWD Articles Average Week Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Evolus News Dianthus Therapeutics News Rapport Therapeutics News Autolus Therapeutics News Cullinan Therapeutics News Oculis News Prothena News Entrada Therapeutics News Arbutus Biopharma News Tectonic Therapeutic News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDWD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDWD Stock Alerts